Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies

dc.contributor.authorGinex, Tiziana
dc.contributor.authorVázquez, Javier
dc.contributor.authorGibert, Enric
dc.contributor.authorHerrero, Enric
dc.contributor.authorLuque Garriga, F. Xavier
dc.date.accessioned2020-06-16T06:49:25Z
dc.date.available2020-06-16T06:49:25Z
dc.date.issued2019-02-25
dc.date.updated2020-06-16T06:49:26Z
dc.description.abstractThe pharmacophore concept is a fundamental cornerstone in drug discovery, playing a critical role in determining the success of in silico techniques, such as virtual screening and 3D-QSAR studies. The reliability of these approaches is influenced by the quality of the physicochemical descriptors used to characterize the chemical entities. In this context, a pivotal role is exerted by lipophilicity, which is a major contribution to host-guest interaction and ligand binding affinity. Several approaches have been undertaken to account for the descriptive and predictive capabilities of lipophilicity in 3D-QSAR modeling. Recent efforts encode the use of quantum mechanical-based descriptors derived from continuum solvation models, which open novel avenues for gaining insight into structure-activity relationships studies.
dc.format.extent17 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec687404
dc.identifier.issn1756-8919
dc.identifier.urihttps://hdl.handle.net/2445/165738
dc.language.isoeng
dc.publisherFuture Science
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.4155/fmc-2018-0435
dc.relation.ispartofFuture Medicinal Chemistry, 2019, vol. 11, num. 10, p. 1177-1193
dc.relation.urihttps://doi.org/10.4155/fmc-2018-0435
dc.rights(c) Future Science, 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)
dc.subject.classificationLipofília
dc.subject.classificationSolvatació
dc.subject.classificationDisseny de medicaments
dc.subject.classificationLligands (Bioquímica)
dc.subject.classificationRelacions estructura-activitat (Bioquímica)
dc.subject.otherLipophilicity
dc.subject.otherSolvation
dc.subject.otherDrug design
dc.subject.otherLigands (Biochemistry)
dc.subject.otherStructure-activity relationships (Biochemistry)
dc.titleLipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
687404.pdf
Mida:
4.67 MB
Format:
Adobe Portable Document Format